Dr. Antonella Santuccione Chadha is a medical doctor with expertise in clinical pathology, neuroscience, and psychiatric disorders. She is head of stakeholder engagement for Alzheimer’s disease at Biogen. She is co-founder and CEO of the non-profit organization “Women's Brain Project”, which is addressing the influence of sex and gender on mental and brain diseases. As a medical doctor, Antonella has decades of experience in preclinical research, patient treatment, clinical development, medical affairs, and setting up the international regulatory framework for Alzheimer's disease. Always focused on solving the puzzles related to Alzheimer's and other psychiatric diseases, she has worked with Swissmedic, Roche, the Bill and Melinda Gates Foundation, several European universities, the EU Commission Directorate for Health and Food Safety, the World Health Organization, the CEO and several Alzheimer's disease organizations. In 2018 and 2019, she was among the top 100 Women in Business in Switzerland and in 2019 she was elected Woman of the Year in Switzerland by the Magazine 'Women in Business'. She is the Vice-president of Euresearch and acts as a scientific advisor for several start-ups and scientific institutions. Dr. Santuccione Chadha is keenly interested in removing bias when developing solutions for mental and neurological diseases to achieve precision medicines. She is advocating and involved in the creation of an institute for sex and gender precision medicine in Switzerland.